ELEVATION ONCOLOGY INC (ELEV)

US28623U1016 - Common Stock

0.536  -0.04 (-6.67%)

Premarket: 0.56 +0.02 (+4.48%)

Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to ELEV. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 7.65. This target is 1327.24% above the current price.
ELEV was analyzed by 13 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about ELEV.
In the previous month the buy percentage consensus was at a similar level.
ELEV was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 0.545.057.657.6510.50 - 842.16% 1,327.24% 1,327.24% 1,858.96%
Up and Down Grades
Date Firm Action Rating
2024-08-07 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-15 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-06-28 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-05-31 Piper Sandler Initiate Overweight
2024-05-14 Stephens & Co. Initiate Overweight
2024-05-03 Wedbush Reiterate Outperform -> Outperform
2024-04-09 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-07 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-03-07 Wedbush Maintains Outperform -> Outperform
2024-03-07 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-01 JMP Securities Initiate Market Outperform
2024-02-20 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-06 Wedbush Reiterate Outperform -> Outperform
2023-09-29 HC Wainwright & Co. Initiate Buy
2023-06-05 Wedbush Maintains Outperform -> Outperform
2023-05-30 SVB Securities Upgrade Market Perform -> Outperform
2023-03-10 Wedbush Reiterate Outperform
2023-01-09 SVB Leerink Maintains Market Perform
2022-11-10 JP Morgan Downgrade Neutral -> Underweight
2022-11-07 SVB Leerink Downgrade Outperform -> Market Perform
2022-08-08 JP Morgan Downgrade Overweight -> Neutral
2022-03-04 Wedbush Maintains Outperform
2021-12-23 HC Wainwright & Co. Initiate Buy
2021-07-20 SVB Leerink Initiate Outperform
2021-07-20 Cowen & Co. Initiate Outperform
2021-07-20 Wedbush Initiate Outperform